About Pharco
Providing safe, effective pharmaceutical products that are affordable and available for every patient all over the globe.
Pharco Pharmaceuticals is one of the dominant players in the pharmaceutical industry in Egypt, the Middle East, and Africa. Our group of companies offers an unparalleled range of pharmaceutical generics and branded generics, alongside other nutritional and vitamin products, for the treatment and prevention of diseases hence improving patient's quality of life. Our contribution to the improvement of healthcare has been significant in the last 30 years, but there is more we would like to accomplish in the near future, as we are constantly seeking new ways to improve the availability of highly effective and affordable medicines. Our goal is to build an autonomous and pre-eminent pharmaceutical industry, by collaborating with national and international scientists and researchers as strategic partners, to ensure that patient needs are fully met from bench to bedside.
Pharco Pharmaceuticals is the mother company of Pharco group, founded by Dr. Hassan Abbas Helmy in 1983. Eight health care companies are operating in the pharmaceutical field for development, manufacturing, marketing, distributing and exporting of a comprehensive array of generics and branded generic drugs under the name of Pharco, along with a rising number of licensed pharmaceutical products. Pharco is the largest manufacturer of pharmaceuticals in the MENA region, focused on research, formulation, manufacturing and commercialization of pharmaceutical products. Today Pharco employs over 8,000 employees, and has over 650 Million packs produced in 2017 — ranking as the leader in the Egyptian pharmaceutical market. Pharco also exports to 50+ countries around the world. Pharco works towards one goal which is to provide highly effective and safe pharmaceutical products to patients at an affordable price. Currently Dr. Sherine Hassan Abbas Helmy (Vice President of Pharco Corporation) is leading the organization after spending 30+ years, gaining massive experience from his father, the founder of Pharco, Dr. Hassan Abbas Helmy.

As Dr. Hassan Abbas Helmy said "providing safe, effective pharmaceutical products that are affordable and available for every patient all over the globe"
is what Pharco is determined to achieve.

Pharco aims to eradicate Hepatitis C World Wide.
By 2020: Egypt free of Hepatitis C
By 2025: Africa free of Hepatitis C
By 2030: A World free of Hepatitis C